Bioventus
Brendan Byrnside, CPA, is a seasoned finance professional with extensive experience in commercial financial planning and analysis, currently serving as Senior Manager of Commercial FP&A at Bioventus since May 2016. In this role, Brendan manages a team overseeing gross to net revenue aspects, including the processing of over $130 million in rebates and chargebacks, and has implemented procedures that identified significant invoice errors impacting revenue reporting. Prior to Bioventus, Brendan held key positions at PwC as Senior Associate, conducting forensic financial analyses related to the Deepwater Horizon oil spill, and training junior staff. Brendan began professional work as a Tax Preparer at Jack Perkins, CPA, and holds both a Bachelor of Science and a Master's degree in Accounting from North Carolina State University and the University of North Carolina Wilmington, respectively.
Bioventus
4 followers
Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process. The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.